Nimotuzumab for Patients With Inoperable Cancer of the Head and Neck

Review

Abstract: EGFR activation induces cell proliferation, neoformation of blood vessels, survival, and metastasis

Palabras claves:

eGFR, head and neck, Monoclonal antibody, nimotuzumab, Radiotherapy

Autores:

Iznaga-Escobar N., Mazorra Z., Mestre Fernández B., Tania Crombet

Fuentes:

scopus